Program: Special-Interest Sessions
Session: ASH Clinicians in Practice (ACIP) Lunch - The Role of Artificial Intelligence in Hematology Practice: The Good, the Bad, and the Ugly
Hematology Disease Topics & Pathways:
Artificial intelligence (AI), Emerging technologies, Technology and Procedures, Imaging
Session: ASH Clinicians in Practice (ACIP) Lunch - The Role of Artificial Intelligence in Hematology Practice: The Good, the Bad, and the Ugly
Hematology Disease Topics & Pathways:
Artificial intelligence (AI), Emerging technologies, Technology and Procedures, Imaging
Sunday, December 8, 2024, 11:15 AM-12:30 PM
Disclosures: Whitfill: PavMed: Current equity holder in publicly-traded company; Healthcare Download: Current equity holder in private company; ClearLabs: Current holder of stock options in a privately-held company.
See more of: ASH Clinicians in Practice (ACIP) Lunch - The Role of Artificial Intelligence in Hematology Practice: The Good, the Bad, and the Ugly
See more of: Special-Interest Sessions
See more of: Special-Interest Sessions
Previous Presentation
|
Next Presentation >>